These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 8972028)

  • 21. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS; Shattil SJ; Power JW; Gartner TK
    J Biol Chem; 1988 Sep; 263(26):12948-53. PubMed ID: 3417645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
    Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure of platelet fibrinogen receptors by a monoclonal antibody to the GPIIb-IIIa complex, PMA4.
    Watanabe A; Hato T; Kobayashi Y
    Int J Hematol; 1992 Aug; 56(1):79-87. PubMed ID: 1382664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPIIIa(90-102) and GPIIIa(631-653) epitopes as markers of conformational changes occurring during the activation of the glycoprotein IIb/IIIa complex.
    Niewiarowska J; Cierniewski CS
    Eur J Biochem; 1994 Sep; 224(3):803-9. PubMed ID: 7523118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of GPIIb- and GPIIIa-specific monoclonal antibodies. Further evidence for the existence of agonist-specific activated states of the platelet fibrinogen receptor.
    de Castellarnau C; Cullaré C; Alvarez MV; Muñiz-Diez E; Calzada MJ; González-Rodríguez J
    Platelets; 1997; 8(4):243-53. PubMed ID: 16793655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties.
    Suzuki K; Sato K; Kamohara M; Kaku S; Kawasaki T; Yano S; Iizumi Y
    Biol Pharm Bull; 2002 Aug; 25(8):1006-12. PubMed ID: 12186399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
    J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinogen fragments and platelet dysfunction in uremia.
    Kozek-Langenecker SA; Masaki T; Mohammad H; Green W; Mohammad SF; Cheung AK
    Kidney Int; 1999 Jul; 56(1):299-305. PubMed ID: 10411706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
    Wittig K; Rothe G; Schmitz G
    Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain.
    Pidard D; Frelinger AL; Bouillot C; Nurden AT
    Eur J Biochem; 1991 Sep; 200(2):437-47. PubMed ID: 1889410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
    Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
    Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
    Mohri H; Ohkubo T
    Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation.
    Gabbeta J; Yang X; Sun L; McLane MA; Niewiarowski S; Rao AK
    Blood; 1996 Feb; 87(4):1368-76. PubMed ID: 8608226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
    Mousa SA; Bozarth J; Forsythe M; Tsao P; Pease L; Reilly TM
    Life Sci; 1994; 54(16):1155-62. PubMed ID: 8152339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitor.
    Kouns WC; Kirchhofer D; Hadváry P; Edenhofer A; Weller T; Pfenninger G; Baumgartner HR; Jennings LK; Steiner B
    Blood; 1992 Nov; 80(10):2539-47. PubMed ID: 1384788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists.
    Jennings LK; Haga JH; Slack SM
    Thromb Haemost; 2000 Dec; 84(6):1095-102. PubMed ID: 11154119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.